Compare Intercept Pharmaceuticals vs Metabolic Solutions Development
Customers evaluate the quality of Intercept Pharmaceuticals's products using the following success metrics.
Overview
Intercept Pharmaceuticals is 22 yrs old and is based in United States.
Intercept is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe, and Canada.
Metabolic Solutions Development is 18 yrs old and is based in United States.
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.
Demo Video
Leadership
Mark Pruzanski (Founder)
Rolf Kletzien (Founder)
Funding
Investors
Genextra, OrbiMed Advisors
SWMF Life Science Fund, Hopen Life Sciences Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Intercept Pharmaceuticals has not claimed their profile.
Work for Intercept Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Intercept Pharmaceuticals?
Claim your profile now.
Information not available because Metabolic Solutions Development has not claimed their profile.
Work for Metabolic Solutions Development? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Metabolic Solutions Development?
Claim your profile now.